Description:
Etanercept contains the active substance called Etanercept with protein structure. Etanercept belongs to a group of medicines called Tumor Necrosis Factor (TNF) Blocking Agent. Etanercept produced by recombinant DNA technology in a Chinese Hamster Ovary (CHO), mammalian expression system. People with autoimmune diseases have excess amount of TNF-α in their bodies which can cause inflammation and lead to painful, swollen joints and dry, itchy, red, scaly patches (psoriatic skin lesions) anywhere on the body. This medicine blocks the activity of TNF-α and prevents TNF-α interactions with its cell surface receptor and as a result, helps to improve inflammation process in your body.
Description:
Adalimumab, is a human monoclonal antibody manufactured by cell culture. Monoclonal antibodies are proteins which bind to other specific proteins. The active substance (Adalimumab) bind to a unique protein called TNFα (Tumor necrosis factor). TNFα causes an elevation in the level of inflammation process in your body.
This medicine is intended for treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, Enthesitis-related arthritis, ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis and non-infectious uveitis.
Description:
TOFACITINIB is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to Methotrexate. It may be used as monotherapy or in combination with Methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs).
Description:
Teriparatide that is used to make the bones stronger, and to reduce the risk of fractures by stimulating bone formation. This drug is used to treat osteoporosis in adults. Osteoporosis is a disease that causes your bones to become thin and fragile. This disease is especially common in women after menopause, but it can also occur in men. Osteoporosis is also common in patients receiving corticosteroids.
Description:
Zoledronic acid injection, is indicated for the treatment of patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy.
Description:
It is indicated in the management of selected adults with severe, active rheumatoid arthritis (RA) (ACRcriteria), or children with active polyarticular juvenile idiopathic arthritis (pJIA), who have
had an insufficient therapeutic response to, or are intolerant of, an adequate trial of first-line therapy including full dose non-steroidal anti-inflammatory agents (NSAIDs).
Description:
Tocilizumab which is a protein made from specific immune cells (monoclonal antibody), that blocks the action of a specific protein (cytokine) called interleukin-6. IL-6 activity in body causes many symptoms of autoimmune disease such as Rheumatoid Arthritis (RA). Blocking IL-6 receptors can reduce the inflammation in your body and reduce symptoms.